Myelofibrosis Treatment Market by Diagnosis Type (Gene Mutation Analysis, Bone Marrow biopsy, Imaging Test, and Blood Tests), by Treatment Type (Chemotherapy, Blood Transfusions, Stem Cell Transplant, Splenectomy, Radiation Therapy, and Others), by Drug Type (Hydroxyurea, Immunomodulators, JAK Inhibitor, and Others), and by End-User (Hospitals, Clinics, and Bone Marrow Transplant Centers): Global Industry Perspective, Comprehensive Analysis and Forecast, 2018 - 2024

Global myelofibrosis treatment market expected to generate revenue of around USD 971.5 million by end of 2024, growing at CAGR of 6.73% between 2018 and 2024. Myelofibrosis is rare bone marrow cancer in which normal bone marrow tissues get changed with scarred tissue which reduces the production of blood cells and increases the production of mutated cells.

11-Jul-2018 | Number of pages: 110 | Report Code: ZMR-3210 | Report Format : | Status : Published

Analysis

Myelofibrosis is a bone marrow cancer or a serious type of leukemia which affects the normal production of blood cells resulting in weakness, anemia, fatigue, and often enlarged spleen. This disease is caused due to the genetic mutation in blood stem cells. These mutated cells keep on dividing themselves which leads to the reduction of red blood cells and can lead to anemia. These genetic mutations in the cells can be caused by various factors such as exposure to radiation, certain chemicals such as benzene or toluene, and other blood cell-related disorders. This disease can be diagnosed by physical examination, blood tests, imaging tests, and bone marrow examination to confirm the presence of disease. Various symptoms such as feeling tired and weak, shortness of breath, fever, easy bleeding, a feeling of pain in bones and joint are observed in the patients of myelofibrosis. This condition can be treated by different therapies, medication, or stem cell transplant.

The epidemiology of myelofibrosis is increasing in the developing economies which results in the increase in demand for treatment options over the forecast period. There are various companies conducting research studies and investing a lot of money in R&D for the development of myelofibrosis drug. There are various drugs which are currently developed by different companies such as CYT387 which is being developed by Gilead Sciences Inc.; CTI BioPharma is trying to modify Pactritinib so that it can be used for the treatment of myelofibrosis and others. Increase in genetic disorders, smoking, reimbursement conditions, and living conditions are also expected to support the growth of myelofibrosis treatment market over the forecast period.

Global Myelofibrosis Treatment Market

Based on the diagnosis type, the myelofibrosis treatment market is segmented into gene mutation, bone marrow biopsy, an imaging test, and blood tests. Treatment type segmentation includes chemotherapy, blood transfusions, stem cell transplant splenectomy, radiation therapy, and others. Based on drug type, the myelofibrosis market is segmented into hydroxyurea, immunomodulators, JAK inhibitors, and others. On the basis of the end user, the myelofibrosis treatment market is segmented into hospitals, clinics, and bone marrow transplant centers.

North America is expected to remain the dominant region over the forecast period which is closely followed by Europe. Due to an increase in the prevalence of myelofibrosis in these regions and an increase in R&D for drug development are aspects expected to support the growth of the myelofibrosis treatment market. The Asia Pacific is expected to be the third largest growing region for the myelofibrosis treatment market due to increase in healthcare facilities, increase in disposable income and an increase in the prevalence of disease. Latin America and the Middle East and Africa are expected to grow moderately over the forecast period.

Some of the key players in myelofibrosis treatment market include Eli Lilly and Company, Gilead Sciences Inc., F. Hoffmann-La Roche Ltd., Incyte Corporation, Merck & Co., Bristol-Myers Squibb Company, Novartis AG, Amgen Inc., and Celgene Corporation, among others.


Related Reports

Hyperhidrosis Treatment Market: By Treatment Type (Botulinum Toxin A, Non-Surgical Microwave Energy Destruction of Sweat Glands, Iontophoresis, Topical Treatments, Surgical Treatments, and Others), By Type (Axillary Hyperhidrosis, Plantar Hyperhidrosis, Palmar Hyperhidrosis, and Others), and By End-User (Hospitals, Ambulatory Surgical Centers, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2019 – 2025

Jan-2020 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-5214 | Report Format:

The report includes Revenue forecast analysis of the hyperhidrosis treatment market on a global as well as regional level. It also offers historic data of 2016 and 2017 and provides a valuation of the industry surge during 2019-2025 in terms of USD Billion. Our study includes competitive strategi...Read More

Home Blood Pressure Monitoring Devices Market: by Product (Upper Arm Monitors, Wrist Monitors, and Accessories), and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Other Distribution Channels): Global Industry Perspective, Comprehensive Analysis and Forecast, 2019 - 2025

Dec-2019 | Price : $ 4199.00 | Pages: 130 | Report Code: ZMR-5131 | Report Format:

According to the report, global demand for home blood pressure monitoring devices market was valued at USD 1,093.1 million in 2018, and is expected to generate revenue of USD 1,611.3 million by end of 2025, growing at a CAGR of 5.7% between 2019 and 2025 The report covers forecast and analysis f...Read More

Orthostatic Hypotension Drugs Market: by Diagnostic Test Type (ECG, Blood Tests, Stress Test and Other), Drug Type (Midodrine, Northera (droxidopa), Fludrocortisone, Caffeine and Others) and End user (Hospitals, ASCs and Clinics and Others) – Global Industry Perspective Comprehensive Analysis and Forecast, 2019-2025

Dec-2019 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-5123 | Report Format:

The report covers forecast and analysis for the Orthostatic Hypotension Drugs market on a global and regional level. The study provides historic data from 2016 to 2018 along with a forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints for the Orthosta...Read More

Carcinoembryonic Antigen Market: by Application (Thyroid Cancer, Prostate Cancer, Ovarian Cancer, Lung Cancer, Breast Cancer, Gastrointestinal Cancer and Other Applications); by End User (Research and Academic Institutes, Diagnostic Centers, Hospitals and Other End Users): Global Industry Perspective, Comprehensive Analysis and Forecast, 2018 - 2025

Dec-2019 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-5122 | Report Format:

The report covers forecast and analysis for the carcinoembryonic antigen market on a global and regional level. The study provides historic data from 2016 along with forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints for the carcinoembryonic antige...Read More

Macular Degeneration Treatment Market: by Drug Class (Anti-VEGFs and Other Drugs); by Indication (Wet Age-related Macular Degeneration (wAMD) and Dry Age-related Macular Degeneration (dAMD)); by Distribution Channel (Ambulatory Surgical Centers, Ophthalmic Clinics and Hospitals): Global Industry Perspective, Comprehensive Analysis and Forecast, 2018 - 2025

Nov-2019 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-5117 | Report Format:

The report covers forecast and analysis for the macular degeneration treatment market on a global and regional level. The study provides historic data from 2016 along with forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints for the macular degenerat...Read More

Request Brochure
Why Choose Us ?

24/5 Research support

Resolved your research queries from industry expert. Request for a research sample before report purchase.

Custom research service

Ask the Analyst to customize an exclusive study to serve your research needs.

Quality & Accuracy

Zion Market Research reports offers best quality reports based on various authentic and accurate data findings.

Customer Satisfaction

We ensure that our client's all research needs are met with customized, in-depth analysis solutions.

Information security

We never share your personal and confidential information. Your personal information is safe and secure with us.